Generalized pustular psoriasis and cryptogenic organizing pneumonia.
Webber
N K
NK
Elston
C M
CM
O'Toole
E A
EA
D017255:Acitretin / Q000008:administration & dosage; D000328:Adult; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy; D018549:Cryptogenic Organizing Pneumonia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D016572:Cyclosporine / Q000009:adverse effects; D003879:Dermatologic Agents / Q000009:adverse effects; D000068800:Etanercept; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects; D018046:Protein C Inhibitor / Q000008:administration & dosage; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage
D003879:Dermatologic Agents; D007074:Immunoglobulin G; D018046:Protein C Inhibitor; D018124:Receptors, Tumor Necrosis Factor; D016572:Cyclosporine; D017255:Acitretin; D000068800:Etanercept